Cargando…
Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study
BACKGROUND: Following the first wave of the COVID-19 pandemic, it was observed that giant cell arteritis (GCA) diagnoses increased at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath, UK. This finding may support the viral aetiology hypothesis of GCA. Better understanding of the ca...
Autores principales: | Mulhearn, Ben, Ellis, Jessica, Skeoch, Sarah, Pauling, John, Tansley, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359857/ https://www.ncbi.nlm.nih.gov/pubmed/37483752 http://dx.doi.org/10.1016/j.heliyon.2023.e17899 |
Ejemplares similares
-
Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19
por: Luther, Rosamond, et al.
Publicado: (2020) -
Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022) -
Rituximab fails to treat giant cell arteritis in a patient with ACPA-positive rheumatoid arthritis
por: Mulhearn, Ben, et al.
Publicado: (2021) -
Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
por: Brekke, L. K., et al.
Publicado: (2017) -
Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)